- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | - | - |
| R2 | - | - |
| R3 | - | - |
| PP | - | - |
| S1 | - | - |
| S2 | - | - |
| S3 | - | - |
Ratios
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| ROCE | - | 7.06 | - | 10.28 | - |
| ROE | - | 2.47 | - | 6.09 | - |
| EPS | -0.33 | 0.02 | 0.04 | 0.3 | 0.1 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Beryl Drugs Ltd
Beryl Drugs Limited was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.
The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations i...
ISIN :INE415H01017
Registrars
Adroit Corp. Services Pvt Ltd
19/20 Jaferbhoy Ind 1st Floor Makwana Rd Marol Naka Mumbai - 400 059
19/20 Jaferbhoy Ind 1st Floor Makwana Rd Marol Naka Mumbai - 400 059
Contact number
+ 022 - 42270400
Management
Sudhir Sethi (Chairman)
Sanjay Sethi (Director)
FAQs
The share price of Beryl Drugs Ltd on the BSE is - as on -